Avitas Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$265K	Buy	372 +42	+13%	+$35.2K	0.04%	184
2024 Q3	$347K	Sell	330 -24	-7%	-$26.7K	0.05%	179
2024 Q2	$372K	Sell	354 -20	-5%	-$19.4K	0.05%	179
2024 Q1	$360K	Sell	374 -8	-2%	-$7.61K	0.05%	188
2023 Q4	$336K	Sell	382 -149	-28%	-$123K	0.06%	179
2023 Q3	$437K	Sell	531 -19	-3%	-$14.9K	0.08%	170
2023 Q2	$395K	Sell	550 -7	-1%	-$5.4K	0.07%	169
2023 Q1	$458K	Sell	557 -20	-3%	-$15.1K	0.09%	160
2022 Q4	$416K	Buy	577 +2	+0.3%	+$1.48K	0.09%	155
2022 Q3	$396K	Buy	575 +2	+0.3%	+$1.26K	0.09%	148
2022 Q2	$339K	Buy	+573	New	+$372K	0.07%	162
2021 Q1	–	Sell	-6,918	Closed	-$3.34M	–	226
2020 Q4	$3.34M	Buy	6,918 +334	+5%	+$180K	0.68%	44
2020 Q3	$3.69M	Buy	6,584 +45	+0.7%	+$27.3K	1.03%	24
2020 Q2	$4.08M	Sell	6,539 -1,092	-14%	-$620K	1.35%	16
2020 Q1	$3.73M	Buy	+7,631	New	+$3.15M	1.7%	12
2019 Q2	–	Sell	-7,350	Closed	-$3.02M	–	176
2019 Q1	$3.02M	Buy	+7,350	New	+$3.03M	0.88%	45